Subclinical atherosclerosis in patients with psoriatic arthritis: a case-control study. Preliminary data

Objective: The aim of this study was to evaluate the prevalence of subclinical atherosclerosis in patients with psoriatic arthritis (PsA), correlated with some traditional risk factors of atherosclerosis and with PsA-related disease factors. Methods: Forty-one patients and 41 healthy subjects were e...

Full description

Bibliographic Details
Main Authors: M. Zanon, M. Puato, M. Lorenzin, V. Modesti, A. Lo Nigro, R. Ramonda, C. Contessa, G. Balbi, A. Doria, L. Punzi
Format: Article
Language:English
Published: PAGEPress Publications 2011-06-01
Series:Reumatismo
Online Access:http://www.reumatismo.org/index.php/reuma/article/view/453
_version_ 1828365157865095168
author M. Zanon
M. Puato
M. Lorenzin
V. Modesti
A. Lo Nigro
R. Ramonda
C. Contessa
G. Balbi
A. Doria
L. Punzi
author_facet M. Zanon
M. Puato
M. Lorenzin
V. Modesti
A. Lo Nigro
R. Ramonda
C. Contessa
G. Balbi
A. Doria
L. Punzi
author_sort M. Zanon
collection DOAJ
description Objective: The aim of this study was to evaluate the prevalence of subclinical atherosclerosis in patients with psoriatic arthritis (PsA), correlated with some traditional risk factors of atherosclerosis and with PsA-related disease factors. Methods: Forty-one patients and 41 healthy subjects were evaluated for intima-media thickness (IMT) and flow-mediated dilation (FMD), using carotid duplex scanning. IMT values were expressed like IMT mean (cumulative mean of all the IMT mean) and M-MAX (cumulative mean of all the higher IMT). Subclinical atherosclerosis markers were correlated with age, body mass index (BMI) and blood pressure in both groups, with duration of arthritis, duration of psoriasis, tender and swollen joints, BASDAI (Bath Ankylosing Spondylitis Disease Activity Index), BASFI (Bath Ankylosing Spondylitis Functional Index), erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) in patients. Results: IMT mean and M-MAX were both higher in PsA patients compared with controls (0.7±0.15 vs 0.62±0.09 mm; p<0.01 and 0.86±0.21 vs. 0.74±0.13 mm; p<0.01 respectively). FMD was smaller in patients than in controls (5.9±2 vs 7.5±2.8%; p<0.01). Univariate analysis showed a correlation between IMT mean and SBP (r=0.217; p=0.05) and a correlation between M-MAX and age (r=0.392; p<0.001), BMI (r=0.252; p<0.05), SBP (r=0.446; p<0.001) in both groups. In PsA patients M-MAX resulted correlated with ESR (r=0.338; p<0.05) and BASDAI (r=0.322; p<0.05). Conclusions: PsA patients exhibited endothelial dysfunctions which is an early marker of subclinical atherosclerosis, as well as an higher IMT. An interesting correlation between M-MAX and PsA activity index (ESR and BASDAI) was found.
first_indexed 2024-04-14T05:26:18Z
format Article
id doaj.art-552a15edc126490aa16340b71c66c154
institution Directory Open Access Journal
issn 0048-7449
2240-2683
language English
last_indexed 2024-04-14T05:26:18Z
publishDate 2011-06-01
publisher PAGEPress Publications
record_format Article
series Reumatismo
spelling doaj.art-552a15edc126490aa16340b71c66c1542022-12-22T02:09:57ZengPAGEPress PublicationsReumatismo0048-74492240-26832011-06-0161429830510.4081/reumatismo.2009.298Subclinical atherosclerosis in patients with psoriatic arthritis: a case-control study. Preliminary dataM. ZanonM. PuatoM. LorenzinV. ModestiA. Lo NigroR. RamondaC. ContessaG. BalbiA. DoriaL. PunziObjective: The aim of this study was to evaluate the prevalence of subclinical atherosclerosis in patients with psoriatic arthritis (PsA), correlated with some traditional risk factors of atherosclerosis and with PsA-related disease factors. Methods: Forty-one patients and 41 healthy subjects were evaluated for intima-media thickness (IMT) and flow-mediated dilation (FMD), using carotid duplex scanning. IMT values were expressed like IMT mean (cumulative mean of all the IMT mean) and M-MAX (cumulative mean of all the higher IMT). Subclinical atherosclerosis markers were correlated with age, body mass index (BMI) and blood pressure in both groups, with duration of arthritis, duration of psoriasis, tender and swollen joints, BASDAI (Bath Ankylosing Spondylitis Disease Activity Index), BASFI (Bath Ankylosing Spondylitis Functional Index), erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) in patients. Results: IMT mean and M-MAX were both higher in PsA patients compared with controls (0.7±0.15 vs 0.62±0.09 mm; p<0.01 and 0.86±0.21 vs. 0.74±0.13 mm; p<0.01 respectively). FMD was smaller in patients than in controls (5.9±2 vs 7.5±2.8%; p<0.01). Univariate analysis showed a correlation between IMT mean and SBP (r=0.217; p=0.05) and a correlation between M-MAX and age (r=0.392; p<0.001), BMI (r=0.252; p<0.05), SBP (r=0.446; p<0.001) in both groups. In PsA patients M-MAX resulted correlated with ESR (r=0.338; p<0.05) and BASDAI (r=0.322; p<0.05). Conclusions: PsA patients exhibited endothelial dysfunctions which is an early marker of subclinical atherosclerosis, as well as an higher IMT. An interesting correlation between M-MAX and PsA activity index (ESR and BASDAI) was found.http://www.reumatismo.org/index.php/reuma/article/view/453
spellingShingle M. Zanon
M. Puato
M. Lorenzin
V. Modesti
A. Lo Nigro
R. Ramonda
C. Contessa
G. Balbi
A. Doria
L. Punzi
Subclinical atherosclerosis in patients with psoriatic arthritis: a case-control study. Preliminary data
Reumatismo
title Subclinical atherosclerosis in patients with psoriatic arthritis: a case-control study. Preliminary data
title_full Subclinical atherosclerosis in patients with psoriatic arthritis: a case-control study. Preliminary data
title_fullStr Subclinical atherosclerosis in patients with psoriatic arthritis: a case-control study. Preliminary data
title_full_unstemmed Subclinical atherosclerosis in patients with psoriatic arthritis: a case-control study. Preliminary data
title_short Subclinical atherosclerosis in patients with psoriatic arthritis: a case-control study. Preliminary data
title_sort subclinical atherosclerosis in patients with psoriatic arthritis a case control study preliminary data
url http://www.reumatismo.org/index.php/reuma/article/view/453
work_keys_str_mv AT mzanon subclinicalatherosclerosisinpatientswithpsoriaticarthritisacasecontrolstudypreliminarydata
AT mpuato subclinicalatherosclerosisinpatientswithpsoriaticarthritisacasecontrolstudypreliminarydata
AT mlorenzin subclinicalatherosclerosisinpatientswithpsoriaticarthritisacasecontrolstudypreliminarydata
AT vmodesti subclinicalatherosclerosisinpatientswithpsoriaticarthritisacasecontrolstudypreliminarydata
AT alonigro subclinicalatherosclerosisinpatientswithpsoriaticarthritisacasecontrolstudypreliminarydata
AT rramonda subclinicalatherosclerosisinpatientswithpsoriaticarthritisacasecontrolstudypreliminarydata
AT ccontessa subclinicalatherosclerosisinpatientswithpsoriaticarthritisacasecontrolstudypreliminarydata
AT gbalbi subclinicalatherosclerosisinpatientswithpsoriaticarthritisacasecontrolstudypreliminarydata
AT adoria subclinicalatherosclerosisinpatientswithpsoriaticarthritisacasecontrolstudypreliminarydata
AT lpunzi subclinicalatherosclerosisinpatientswithpsoriaticarthritisacasecontrolstudypreliminarydata